Zobrazeno 1 - 10
of 22
pro vyhledávání: '"Ioannis D. Xynos"'
Publikováno v:
Emerging Infectious Diseases, Vol 15, Iss 6, Pp 956-959 (2009)
We report 2 cases of leishmaniasis in patients with autoimmune rheumatic diseases in Greece. To assess trends in leishmaniasis reporting in this patient population, we searched the literature for similar reports from Europe. Reports increased during
Externí odkaz:
https://doaj.org/article/3abcaf88640146d389ca13aebc81fe2c
Autor:
Konstantinos A. Kontoangelos, Anastasios V. Kouzoupis, Panagiotis P. Ferentinos, Ioannis D. Xynos, Nikolaos V. Sipsas, George N. Papadimitriou
Publikováno v:
Case Reports in Psychiatry, Vol 2013 (2013)
Background. Ankylosing spondylitis (AS) is a systemic inflammatory disease with chronic back pain as the most common presenting symptom. We present a case of a male patient with AS reporting symptoms of severe low back pain, buttock pain, and limited
Externí odkaz:
https://doaj.org/article/33674a05524b4367ad053552cdd0d5d4
Autor:
Christos Kosmas, Kalliopi Athanasiadou, Periclis Tomos, Nikolaos Koufos, Despina Michailidou, Ioannis D. Xynos, Nikolaos Tsavaris
Publikováno v:
Journal of Cancer Research and Clinical Oncology. 139:1995-2003
The aim of this study was to assess systemic immunological responses in non-small-cell lung cancer (NSCLC) patients with stage III/IV disease during treatment with paclitaxel–ifosfamide–cisplatin (TIP) chemotherapy. Peripheral blood mononuclear c
Autor:
Angelos D. Gritzapis, Elias Skopelitis, Sousana Amptoulach, Christos Kosmas, Ioannis D. Xynos, N. Tsavaris, Maria L. Karadima, Ioannis F. Voutsas
Publikováno v:
Oncology. 84:273-283
Objective: To identify changes in peripheral immune responses in patients with metastatic colorectal cancer (mCRC) treated with irinotecan/5-fluorouracil/leucovorin (IFL) alone or in combination with cetuximab (C-IFL). Methods: Peripheral blood monon
Publikováno v:
The Journal of Clinical Endocrinology & Metabolism. 95:3277-3281
Data from previous retrospective studies and case reports have suggested that infectious diseases of the central nervous system could cause pituitary deficiency.The aim of this prospective study was to investigate pituitary function in patients admit
Autor:
Christos Kosmas, John Syrios, Stamatis Kakaris, Despina Michailidou, Periclis Tomos, Nikolaos Koufos, Nicolaos Kavantzas, N. Tsavaris, Andreas C. Lazaris, Ioannis D. Xynos
Publikováno v:
Molecular and clinical oncology. 5(4)
The expression of various angiogenic factors was assessed in tumour samples of patients with stage III non-small-cell lung cancer (NSCLC) and further evaluated in terms of response to induction paclitaxel-ifosfamide-cisplatin chemotherapy. Freshly is
Publikováno v:
Journal of Biomedical Materials Research. 55:151-157
The effect of the ionic products of Bioglass 45S5 dissolution on the gene-expression profile of human osteoblasts was investigated by cDNA microarray analysis of 1,176 genes. Treatment with the ionic products of Bioglass 45S5 dissolution increased th
Publikováno v:
Materials Research Innovations. 3:313-323
Many of the present generation biomaterials are still based upon the early concept that implantable materials should be bioinert and therefore designed to evoke minimal tissue response, if none. However, a growing body of clinical data demonstrates t
Publikováno v:
Expert review of anticancer therapy. 14(2)
The identification of patients who are more likely to derive benefit from antiangiogenic therapy is a key to refine patient selection and so maximize clinical benefit, and reduce unnecessary treatment costs. Improved patient selection will equally be
Autor:
Andreas C. Lazaris, John Sarantonis, Christos Kosmas, Efstratios Patsouris, George Agrogiannis, N. Tsavaris, Dimitrios Tzivras, Ioannis D. Xynos, Stavros Sougioultzis, Nicolaos Kavantzas, Michalis Zacharakis, Aris Polyzos, Smaro Tsaousi
Publikováno v:
ISRN Gastroenterology
Objective. To evaluate the prognostic significance of microscopically assessed DNA ploidy and other clinical and laboratory parameters in stage IV colorectal cancer (CRC). Methods. 541 patients with histologically proven stage IV CRC treated with pal